Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

FDA-Licensed Blood Donor Testing Laboratory Services

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

621991 - Blood and Organ BanksView NAICS

Place of Performance

Fort Gordon, GA, 30905, USA

Set-Aside

NONE

Documents

This scope was carved out of HT9406-26-Q-E098.

The full solicitation package (4 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Blood Donor Testing Services

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs comprehensive off-site infectious disease screening and blood bank reference laboratory testing for prime contractors on Defense Health Agency projects. Executes ABO/Rh, Antibody Screen, NAT panels (WNV, HIV, HCV, HBV), and confirmatory testing for reactive results. Requires FDA-approved instrumentation, FDA Blood Establishment Registration/License, and CLIA compliance. Delivers validated test results via secure portal within 24 hours.

Similar Contracts

Same NAICS industry code

NAICS: 621991
SLED
Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.
HOUSTON-GALVESTON AREA COUNCIL

POSTED

about 2 months ago

DEADLINE

in 11 months
View Details
NAICS: 621991
Grant
Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)The National Mesothelioma Virtual Bank (NMVB), funded by the Centers for Disease Control and Prevention under the Department of Health and Human Services, is being extended and expanded to enhance translational research for malignant mesothelioma. This initiative aims to broaden the collection of biospecimens including fresh frozen and paraffin-embedded tumor and control tissues, blood, DNA, RNA, and protein samples from patients, alongside comprehensive demographic data such as age, sex, race, and occupational history, and detailed clinical information including disease stage, treatment regimens, and survival outcomes. The NMVB functions as a virtual repository that provides researchers with centralized access to a growing library of biospecimens and associated genomic, transcriptomic, and proteomic datasets to accelerate scientific discovery. The program supports critical research goals such as identifying early indicators of mesothelioma, developing biomarkers for accurate disease staging and prognosis prediction, and facilitating the creation of new or improved therapeutic strategies. By integrating diverse data types and maintaining a shared resource accessible to the broader scientific community, the NMVB strengthens collaboration across biomedical and clinical research fields. This continuation and expansion effort is designed to increase the depth, breadth, and utility of the database, ensuring that researchers worldwide can leverage this resource to advance understanding and treatment of malignant mesothelioma. The opportunity is open for applications through the CDC’s grant mechanism, with scientific program oversight provided by Dr. Bridgette Garrett.
Centers For Disease Control And Prevention

POSTED

about 2 months ago

DEADLINE

N/A
View Details

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 524114
New
Federal
PILOT PROGRAM TO ASSIST CERTAIN MEMBERS OF THE ARMED FORCES AND DEPENDENTS WITH ADDITIONAL SUPPLEMENTAL COVERAGE RELATING TO CANCER HT9402-26-RFI-0255
Solicitation # HT9402-26-RFI-0255
The Defense Health Agency is conducting market research via a Request for Information to establish a pilot program for supplemental cancer insurance. Mandated by the National Defense Authorization Act for Fiscal Year 2026, the program aims to provide members of the Army, Navy, Marine Corps, Air Force, and Space Force, along with their dependents, with fixed indemnity benefits to cover noncovered expenses related to cancer screening, diagnosis, and treatment. The pilot must be established by September 30, 2027, and will be a no-cost initiative to the government, meaning it must be 100 percent beneficiary paid. Interested carriers must submit written responses by September 18, 2026, addressing specific topics including plan types, coverage scope, exclusions, eligibility, and enrollment processes. The government is seeking detailed information on how these plans would handle non-FDA approved drugs, clinical trials, and overseas care, as well as the administrative burden on beneficiaries regarding premium payments and claims processing. Responses should also detail the provider's experience in supplemental insurance, data protection measures, and the feasibility of participating in a no-cost contract structure.
Direct Health and Medical Insurance Carriers

POSTED

2 days ago

DEADLINE

in 12 days
View Details